Lodo Therapeutics Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 34
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $19.9M
Latest Deal Amount
  • Investors
  • 14

Lodo Therapeutics General Information

Description

Developer of novel cancer and anti-infective therapeutics created to address undruggable targets with high unmet need. The company applies advanced technologies to tap the vast collections of undiscovered molecules encoded in microbial DNA that is extracted from the environment, thus enabling healthcare providers to treat drug-resistant microbial infections and cancers.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 430 East 29th Street
  • Suite 625
  • New York, NY 10016
  • United States
+1 (646) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Lodo Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 18-Jan-2016 $19.9M 000.00 0000 Completed Generating Revenue
To view Lodo Therapeutics’s complete valuation and funding history, request access »

Lodo Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000,000 00.000000 00 00 00 00 00.000
To view Lodo Therapeutics’s complete cap table history, request access »

Lodo Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of novel cancer and anti-infective therapeutics created to address undruggable targets with high unmet need. T
Drug Discovery
New York, NY
34 As of 2020
000.00
000 0000-00-00
00000000000 000.00

00000000

is nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dol
0000000000000
Waltham, MA
00 As of 0000
00000
0000 0000-00-00
000000&0 00000

000000 0

Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariat
0000000000000
Cambridge, MA
000 As of 0000
00000
000000 - 000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Lodo Therapeutics Competitors (28)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Visterra Formerly VC-backed Waltham, MA 00 00000 000000&0 00000
000000 00000000000 Corporation Cambridge, MA 000 00000 000000 - 000 00000
00000000 Venture Capital-Backed Carrollton, TX 00 000.00 00 000000 000.00
0000000 0000000000 Formerly VC-backed Redwood City, CA 000 00000 000000000 00000
00 000000000000 Formerly VC-backed Durham, NC 000 00000 000000 - 000 00000
You’re viewing 5 of 28 competitors. Get the full list »

Lodo Therapeutics Executive Team (7)

Name Title Board Seat Contact Info
Dale Pfost Ph.D Chief Executive Officer & Chairman
Donald Marvin Chief Financial Officer & Executive Vice President
Steve Colletti Chief Scientific Officer
Sean Brady Ph.D Co-Founder & Academic Advisor
Brad Hover Vice President, Discovery Research and Platform Technology
You’re viewing 5 of 7 executive team members. Get the full list »

Lodo Therapeutics Board Members (11)

Name Representing Role Since
Dale Pfost Ph.D Lodo Therapeutics Chief Executive Officer & Chairman 000 0000
Johnston Erwin Lodo Therapeutics Board Member 000 0000
Nikola Trbovic Ph.D Self Board Member 000 0000
Steve Gillis Lodo Therapeutics Board Member 000 0000
Sundar Kodiyalam Self Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

Lodo Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lodo Therapeutics Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
180 Degree Capital Venture Capital Minority 000 0000 000000 0
AbbVie Ventures Corporate Venture Capital Minority 000 0000 000000 0
Accelerator Life Science Partners Venture Capital Minority 000 0000 000000 0
Alexandria Venture Investments Corporate Venture Capital Minority 000 0000 000000 0
ARCH Venture Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »

Lodo Therapeutics Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 000000000 03-Sep-2020 000000000000000000 Biotechnology 0000 00000 00.0
Conifer Point Pharmaceuticals 06-Aug-2020 Merger/Acquisition Other Healthcare Technology Systems 0000 00000 00.0
To view Lodo Therapeutics’s complete acquisitions history, request access »

Lodo Therapeutics Subsidiaries (2)

Company Name Industry Location Founded
Hibiskus BioPharma Biotechnology Kalamazoo, MI 2017
0000000 00000 0000 Other Healthcare Technology Systems Doylestown, PA 0000
To view Lodo Therapeutics’s complete subsidiaries history, request access »